Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary?

Authors Information
Article Notes and Dates
To Cite : Mirzaei J, Ziaee M, Farsad S A, Fereydooni M, Anani Sarab G, et al. Vaccination Against Hepatitis A for Hemophilic Patients: Is It Necessary?, Hepat Mon. 2016 ;16(4):e37447. doi: 10.5812/hepatmon.37447.
Copyright: Copyright © 2016, Hepatitis Monthly. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited..
Abstract
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnotes
References
  • 1. SAGE Hepatitis A Working Group . Evidence based recommendations for use of hepatitis A vaccines in immunization services: Background paper for SAGE discussions. WHO. 2011; : 1-12
  • 2. Cuthbert JA. Hepatitis A: old and new. Clin Microbiol Rev. 2001; 14(1): 38-58[DOI][PubMed]
  • 3. Hussain Z. Genomic Heterogeneity of Hepatitis Viruses (AE): Role in Clinical Implications and Treatment. Pract Manage Chronic Viral Hepat. 2013;
  • 4. Poovorawan Y, Chatchatee P, Chongsrisawat V. Epidemiology and prophylaxis of viral hepatitis: a global perspective. J Gastroenterol Hepatol. 2002; 17 Suppl-66[PubMed]
  • 5. Vitral CL, Ospina FL, Artimos S, Melgaco JG, Cruz OG, de Paula VS, et al. Declining prevalence of hepatitis A virus antibodies among children from low socioeconomic groups reinforces the need for the implementation of hepatitis A vaccination in Brazil. Mem Inst Oswaldo Cruz. 2012; 107(5): 652-8[PubMed]
  • 6. Tanaka J. Hepatitis A shifting epidemiology in Latin America. Vaccine. 2000; 18 Suppl 1-60[PubMed]
  • 7. Chen JY, Chiang JC, Lu SN, Hung SF, Kao JT, Yen YH, et al. Changing prevalence of anti-hepatitis A virus in adolescents in a rural township in Taiwan. Chang Gung Med J. 2010; 33(3): 321-6[PubMed]
  • 8. Jacobsen KH, Koopman JS. Declining hepatitis A seroprevalence: a global review and analysis. Epidemiol Infect. 2004; 132(6): 1005-22[PubMed]
  • 9. Lee A, Lim HS, Nam CM, Song SM, Yoon HR, Lee KR. [An epidemiological analysis of hepatitis A virus serologic markers during the recent four years in Korea]. Korean J Lab Med. 2009; 29(6): 563-9[DOI][PubMed]
  • 10. Brundage SC, Fitzpatrick AN. Hepatitis A. Am Fam Physician. 2006; 73(12): 2162-8[PubMed]
  • 11. Atkinson W. Epidemiology and prevention of vaccine-preventable diseases. 2005;
  • 12. Tantawy AA, Algohary EA, El-Ghany SM, Elhadary SF. Haemophilia A patients are not at increased risk of hepatitis A virus infection: An Egyptian experience. Egyptian J Med Human Genet. 2012; 13(1): 93-7
  • 13. Richardson LC, Evatt BL. Risk of hepatitis A virus infection in persons with hemophilia receiving plasma-derived products. Transfus Med Rev. 2000; 14(1): 64-73[PubMed]
  • 14. Mauser-Bunschoten EP, Damen M, Zaaijer HL, Sjerps M, Roosendaal G, Lelie PN, et al. Hepatitis G virus RNA and hepatitis G virus-E2 antibodies in Dutch hemophilia patients in relation to transfusion history. Blood. 1998; 92(6): 2164-8[PubMed]
  • 15. Samimi-Rad K, Shahbaz B. Hepatitis C virus genotypes among patients with thalassemia and inherited bleeding disorders in Markazi province, Iran. Haemophilia. 2007; 13(2): 156-63[DOI][PubMed]
  • 16. Srivastava A, Brewer AK, Mauser-Bunschoten EP, Key NS, Kitchen S, Llinas A, et al. Guidelines for the management of hemophilia. Haemophilia. 2013; 19(1)-47[DOI][PubMed]
  • 17. Cho SE, Kim Y. Seroepidemiology of hepatitis a in South Korea: a nationwide study by the Eone Reference Laboratory. J Epidemiol. 2013; 23(4): 270-4[PubMed]
  • 18. Molina R, Lorenzo JI, Gomez MD, Sarrion A, Haya S, Querol F, et al. [Seroprevalence of hepatitis A in hemophiliacs]. Sangre (Barc). 1996; 41(5): 363-5[PubMed]
  • 19. Mauser-Bunschoten EP, Zaaijer HL, van Drimmelen AA, van den Berg HM, Roosendaal G, Lelie PN. Risk of hepatitis A in Dutch hemophilia patients. Thromb Haemost. 1995; 74(2): 616-8[PubMed]
  • 20. Hayashi K, Fukuda Y, Nakano I, Katano Y, Nagano K, Yokozaki S, et al. Infection of hepatitis A virus in Japanese haemophiliacs. J Infect. 2001; 42(1): 57-60[DOI][PubMed]
  • 21. Taghavi Ardakani A, Soltani B, Sehat M, Namjoo S, Haji Rezaei M. Seroprevalence of anti-hepatitis a antibody among 1 - 15 year old children in kashan-iran. Hepat Mon. 2013; 13(5)[DOI][PubMed]
  • 22. Merat S, Rezvan H, Nouraie M, Abolghasemi H, Jamali R, Amini-Kafiabad S, et al. Seroprevalence and risk factors of hepatitis A virus infection in Iran: a population based study. Arch Iran Med. 2010; 13(2): 99-104[PubMed]
  • 23. Saberifiroozi M. Hepatitis A virus infection: Is it an important hazard to public health?: hazards of HAV for public health. Hepat Mon. 2011; 11(4): 235-7[PubMed]
  • 24. Farzadegan H, Shamszad M, Noori-Arya K. Epidemiology of viral hepatitis among Iranian population--a viral marker study. Ann Acad Med Singapore. 1980; 9(2): 144-8[PubMed]
  • 25. Ataei B, Javadi AA, Nokhodian Z, Kassaeian N, Shoaei P, Farajzadegan Z, et al. HAV in Isfahan province: a population-based study. Trop Gastroenterol. 2008; 29(3): 160-2[PubMed]
  • 26. Masuet-Aumatell C, Ramon-Torrell JM, Casanova-Rituerto A, Banque-Navarro M, Davalos-Gamboa M, Montano-Rodriguez SL. Prevalence of hepatitis A antibodies in Eastern Bolivia: a population-based study. J Med Virol. 2013; 85(10): 1692-7[DOI][PubMed]
  • 27. Taghavi SA, Hosseini Asl MK, Talebzadeh M, Eshraghian A. Seroprevalence study of hepatitis A virus in Fars province, southern Iran. Hepat Mon. 2011; 11(4): 285-8[PubMed]
  • 28. Chambost H, Doncarli A, Bertrand MA, Briquel ME, Gay V, Pincemaille O, et al. Implementation of a hepatitis A prevention policy in haemophiliacs: results from the French cohort. Haemophilia. 2007; 13(6): 712-21[DOI][PubMed]
  • 29. Rafiei A, Darzyani AM, Taheri S, Haghshenas MR, Hosseinian A, Makhlough A. Genetic diversity of HCV among various high risk populations (IDAs, thalassemia, hemophilia, HD patients) in Iran. Asian Pac J Trop Med. 2013; 6(7): 556-60[DOI][PubMed]
  • 30. Jahanbakhsh Sefidi F, Keyvani H, Monavari SH, Alavian SM, Fakhim S, Bokharaei-Salim F. Distribution of hepatitis C virus genotypes in Iranian chronic infected patients. Hepat Mon. 2013; 13(1)[DOI][PubMed]
  • 31. Jamil LH, Duffy MC, Fakhouri M, Jamil HJ. Prevalence of antibodies to the hepatitis C virus among Arab and Chaldean Americans in southeast Michigan, USA. Ethn Dis. 2013; 23(1): 18-21[PubMed]
  • 32. Kupfer B, Ruf T, Matz B, Nattermann J, Spengler U, Rockstroh JK, et al. Comparison of GB virus C, HIV, and HCV infection markers in hemophiliacs exposed to non-inactivated or inactivated factor concentrates. J Clin Virol. 2005; 34(1): 42-7[DOI][PubMed]
  • 33. Chakrabarti S, Pradhan P, Roy A, Hira M, Bandyopadhyay G, Bhattacharya DK. Prevalence of anti HCV, HBsAg and HIV antibodies in high risk recipients of blood and blood products. Indian J Public Health. 2006; 50(1): 43-4[PubMed]
  • 34. Alavian S, Ardeshir A, Hajarizadeh B. Seroprevalence of anti-HCV among Iranian hemophilia patients. Transfus Today . : 3-5
  • 35. Sharifi-Mood B, Eshghi P, Sanei-Moghaddam E, Hashemi M. Hepatitis B and C virus infections in patients with hemophilia in Zahedan, southeast Iran. Saudi Med J. 2007; 28(10): 1516-9[PubMed]
  • 36. Borhany M, Shamsi T, Boota S, Ali H, Tahir N, Naz A, et al. Transfusion transmitted infections in patients with hemophilia of Karachi, Pakistan. Clin Appl Thromb Hemost. 2011; 17(6): 651-5[DOI][PubMed]
  • 37. Fathimoghaddam F, Hedayati-Moghaddam MR, Bidkhori HR, Ahmadi S, Sima HR. The prevalence of hepatitis B antigen-positivity in the general population of Mashhad, Iran. Hepat Mon. 2011; 11(5): 346-50[PubMed]
  • 38. Ghafouri M, Ameli M. Comparing prevalence of transfusion transmitted viral infections in various population groups of South Khorasan. Sci Iranian Blood Transfus Organiz (Khoon). 2011; 7(29): 242-68
  • 39. Ziaee M, Zarban A, Malekinejad P, Akhbary H. Evaluation of HGV viremia prevalence and its co-infection with HBV, HCV, HIV and HTLV-1 in hemophilic patients of Southern Khorassan, Iran. Hepat Mon. 2007; 7(1): 11-4
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .

Search Relations:

Author(s):

Article(s):

Create Citiaion Alert via Google Reader

Cited By:

Hepatitis Monthly accepts terms & conditions of:

International Committee of Medical Journal Editors (ICMJE) Citedby Linking DOI enabled Crossref iThenticate COPE Cross Check